Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial.

导出 OA

翻译打印收藏纠错

第一作者： Jieyun,Xia

第一单位： Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.

作者： Jieyun,Xia ^[1] ; Hujun,Li ^[2] ; Zhiling,Yan ^[3] ; Dian,Zhou ^[1] ; Ying,Wang ^[2] ; Yuekun,Qi ^[3] ; Jiang,Cao ^[1] ; Depeng,Li ^[2] ; Hai,Cheng ^[3] ; Wei,Sang ^[1] ; Feng,Zhu ^[2] ; Haiying,Sun ^[3] ; Wei,Chen ^[1] ; Kunming,Qi ^[2] ; Dongmei,Yan ^[3] ; Tingting,Qiu ^[1] ; Jianlin,Qiao ^[2] ; Ruosi,Yao ^[3] ; Yang,Liu ^[1] ; Xue,Wang ^[2] ; Yanlei,Zhang ^[3] ; Shuixiu,Peng ^[1] ; Chih-Hua,Huang ^[2] ; Junnian,Zheng ^[3] ; Zhenyu,Li ^[1] ; Alex H,Chang ^[2] ; Kailin,Xu ^[3]

作者单位： Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China. ^[1] Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. ^[2] Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China. ^[3] Shanghai YaKe Biotechnology Ltd, Shanghai, China. ^[4] Cancer Institute, Xuzhou Medical University, Xuzhou, China. ^[5] Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. ^[6] Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. ^[7]